Cyril Titeux is Company Group Chairman, Johnson & Johnson Innovative Medicine Asia Pacific, and a member of the Innovative Medicine Group Operating Committee (GOC), overseeing the business which focuses on meeting the needs of patients, healthcare providers, and government health bodies across key markets in the region. These include Japan, China, Australia & New Zealand, South Korea, Singapore, and more.
